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Medical mysteries get solved at a remarkable rate these days. This is particulary
true when the mysteries involve mechanisms rather than therapeutic stratagems. Of
course, the scientific force tackling these cases is larger than ever and certainly better
equipped and trained than in previous ages. Medical detective work is incredibly
expensive but, with arguments about priorities excluded, few would doubt the quality
of the benefits so bought. There remain, however, a number of problem cases that
still defy solution despite the collection of ever-increasing pieces ofthejigsaw puzzle.
There is little doubt that authors in 2028 reviewing medical concepts puzzled over
in 1978 will experience two reactions. They will look condescendingly at the concepts
of earlier colleagues who all in all did remarkably well in the scientifically primitive
1970s. However, these future reviewers will probably feel some disquiet as they
realize the fact that certain basic questions that they found raised in the 1970s have
answers that are still unknown. The 1920s that are fifty years past have provided an
article for contemporary comment that is the purpose ofthis paper but engendered in
this reviewer the reactions outlined above.
In Volume 1 of The YaleJournalofBiology andMedicine(1928-1929), Dr. James
D. TraskI tackled the subject of comparative immunology in pediatrics. It makes
fascinating if difficult reading for the modern physician/immunologist. Fashions
change, and both the style of writing and the diseases discussed have largely
disappeared from our environment. The disappearance of the former has many
regrettable aspects. Trask's style is verbose by modern standards and speaks for an
editorial largesse not likely to be accorded this comparator. With a few "dear
readers" scattered around we could have an "O'Henry" style discourse that, while
admittedly unnecessary, has a cultured ring to it and emphasizes the art as well as the
science that is medicine. Such phrases as "cannot at present be answered positively,'
"it might be pointed out," and .... warrants the serious consideration of another
hypothesis," have long since departed from medical literature.
The author was concerned with three subjects in this paper. The first was
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All rights of reproduction in any form reserved.summarized at the end of the paper: are the "artificial boundaries" that limit a
physician's practice to Medicine, Pediatrics, Obstetrics, etc., detrimental to medical
progress? Clearly, the warning he sounded then is even more relevant today. The
problem has been compounded, so compounded by the development of knowledge
that the application of these advances in medicine can only be delivered by further
medical compartmentalization. This conventional wisdom worries many of us and it
is unlikely that our present habits would be regarded as improvements by Dr. Trask.
He would, however, be delighted and even amazed by the advances that have
occurred in a second area that concerned him as the 1920s closed. Why, he lamented,
are not the immunological approaches so recently espoused by Elie Metchnikoff
being applied to clinical studies of immunological problems? Immunology in Trask's
context meant natural and provoked host defense mechanisms against infectious
agents. He points out that much had been learnt by phylogenetic comparisons. The
response to similar antigens amongst many vertebrate and invertebrate subjects had
been shown to vary enormously. Metchinikoff had even provided evidence for
infectious diseases amongst plants. Immunology, said Trask, was concentrating too
much on preparing pure bacterial antigens and not enough on the variability ofthe
host's response to these antigens. Could not a child's immune response be as different
from an adult's as the response of invertebrate hosts is to that of vertebrates?
Modern immunologists have constructed a remarkably detailed picture of the
phylogenetic evolution of our immune system. We now know that biological systems
use defense mechanisms that range from non-specific phagocytosis, first observed
when Metchnikoff introduced a rose's thorn into the protoplasm of a primitive
jellyfish, to specific mechanisms that can harness all inflammatory processes, exhibit
memory, and can distinguish with unbelievable sensitivity self antigens from foreign
antigens. Of the two weapon systems that comprise ourimmune system we know that
cell-mediated immunity is phylogenetically older, being present in primitive earth-
worms. Humoral immune mechanisms that result inantibody production represent a
more recent addition to our defenses. It was in the primitive sharks with their
primitive IgM-like molecules that nature first experimented with an antibody system
whose evolution was clearly pressured by the success being enjoyed by pathogenic
bacteria. Trask and similarly interested contemporaries would surely be fascinated to
know that modern immunology, having observed the phylogenetic development of
specific immunity by comparative immunological studies, can now see the whole
complicated and wondrous achievements of many a millennium repeated in every
human embryo where phylogeny is recapitulated in ontogeny in a 16-week period.
It was Metchinikoff's colleague and co-Nobel prize winner, Paul Ehrlich, who
proposed that cells (lymphocytes) must be genetically programmed during fetal life
while remote from antigenic encounter so that they might possess cell surface
receptors that would allow any one cell to recognize but one antigen. With this
antigen bound to its surface a cellular response would follow that would specifically
eliminate the offending antigen. It took more than 60 years ofinvestigation to prove
Ehrlich's hypothesis but it is now the cornerstone of modern immunological
knowledge. If the cell encountering antigen was educated in the thymus, we get a cell-
mediated immune response (e.g., delayed hypersensitivity). Ifthe cell was educated in
the bone marrow, it divides to form a plasma cell that secretes antibodies. Clinical
immunologists can now diagnose defects in what is normally an obligatory matura-
tional sequence that provides us with the capacity to produce a heterogeneous
immune response. Congenital immune deficiencies are in fact classified according to
this concept.
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If we were comparative in the above sense, we are now entering a phase of
comparative immunology recognized as essential by Trask but expanded far beyond
his original concept. Study variability of the host's response, he urged; what is the
effect of age on the immune response; why do we have individual variability to
antigenic stimulation?
It can be stated confidently that the major thrust of modern immunology at both
the basic and clinical level is designed to answer these very questions.
We know that the immune system deteriorates with age and we know that it
deteriorates faster in some individuals than others, but, like Dr. Trask, we believe
that the "variability of the host" is most important in the area of immunoregulation.
Suspicions of a thymus-dependent system had not developed in 1928 but in the 1970s
we are preoccupied by a study of one of at least three types of cells produced by this
gland. Apart from the effector cells that provide aninflammatory response known as
delayed hypersensitivity, and which protect us from viral and fungal infections
amongst other things, we have another "T' cell concerned with immunoregulation.
This cell acts as an immunological sensor that is responsible for the appropriateness
of the effector response provided by both the humoral and cell-mediated systems.
The immunoregulatory T cell seems to function according to genetic information
encoded close to the area of the D locus ofthe sixth chromosome in man. In any two
individuals the genes occupying these loci can differ (alleles), and it is becoming
increasingly clear that we are not all born equal in this area of immunoregulation.
Numerous diseases are now being associated with specific gene clusters in this area.
Immunologists have mapped in detail the equivalent area in the mouse and provided
enormous amounts of evidence for the genetic control of both immunoregulatory
phenomena and antigen recognition skills. Thus, Trask was correct when he
suspected that encounters with similar environmental agents could provoke entirely
different responses in individual hosts.
The third matter discussed by Dr. Trask raised specific questions about the
immune response to three infectious diseases that are no longer of importance
clinically in economically blessed countries. Scarlet fever, diphtheria, and tetanus
were the diseases chosen for comparison. Scarlet fever seems to have disappeared
without any intervention from man and prior to the antibiotic era. The decreases in
diphtheria and tetanus have been a direct consequence of man's application of
immunological principles to the control of disease by immunization. That these
measures are not widely enough applied throughout theworld was evident in a recent
trip to Africa by the author where tetanus is still a significant problem. Parentheti-
cally, one might also point out that even in developed countries like the United States
effective control measures for tetanus, diphtheria, measles, and poliomyelitis are
lagging, especially in inner city slums.
Trask is troubled by apparent inconsistencies in the immune response to the toxins
associated with these diseases. Had there been more knowledge at that time about
species specificity of bacteria, some of his questions regardingthe lack ofsusceptibil-
ity in certain animals would have been unnecessary. Again, some of his questions
concerning the similarity of human immune responses between mothers and their
newborn offspring would have been easily answered had he known that from the
eighteenth week ofgestation maternal IgG (and only IgG) crosses the placenta so that
at birth the baby has adequate adult concentrations of passively acquired maternal
IgG in its circulation. The baby is thus capable of making a humoral immune
response to all the antigens to which the motheris immune. This antibody has a half-
life of 30 days and thus, by the sixth month of life, it has nearly disappeared. If the
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not ready to switch to IgG production, the infant's host defense mechanisms will be
severely compromised.
There are, however, some very specific questions that we should try to answer, and
it is disquieting that some of these questions cannot bie easily answered.
The questions raised concerned the Dick test and the Schick test. The former was
used to diagnose the presence of antibodies against the streptococcal erythrogenic
toxin that produced the rash of scarlet fever. Subcutaneous injection of cultured
toxin produced an inflammatory response unless neutralized by antibody. A similar
principle was used with the Schick test, which utilized diphtheria toxin.
The observations that Trask found interesting and inexplicable and yet suitable for
comparative study follow. They are all excellent questions.
1. Why is it that only man is susceptible to the scarlet fever toxin? Although
rabbits could be manipulated to make them susceptible and could subsequently be
protected with antitoxin, man was the only natural victim. We don't know the answer
to this first question. Not much work has been done in this area in recent years,
probably because streptococci are less commonly producingerythrogenictoxin. Why
this should be the case is not clear. The production of the toxin by streptococci is
dependent on specific phage infection ofthe bacteria that alter the DNA ofthe cell to
produce toxin. Of course, there is no certainty that the question could have been
answered even if the necessary research effort had been made. We can guess, by
extrapolating from similar better known situations, that species-specific receptors for
the erythrogenic toxin must exist. These may well be on non-specific cells that are
activated to produce an inflammatory response.
2. The study of 200 mothers and their newborn offspring showed that the majority
of infants shared the same antitoxin (antibody) status as their mothers. This, no
doubt, was due to placental transfer of IgG antibody from mother to fetus. Such
infants would not have been expected to develop an inflammatory response in the
skin to Dick reagent. However, a few infants with no detectable antibody to the
erythrogenic toxin still did not produce a positive response to intradermal injections
of the toxin of scarlet fever. This suggested to Trask that neonates could not mount
the inflammatory response in the skin seen in older children. He reasoned that as
such infants could still suffer from fatal infections with the erythrogenic-producing
streptococci, it must be unlikely that the erythrogenic toxin itself was the major
producer of the disease's morbidity.
We believe today that he was correct in this latter assumption. While the
erythrogenic toxin probably has some effects at sites other than skin, it is not
considered to contribute significantly to the potentially serious sequelae of infection
with this type of streptococcal organism.
3. Why is it that Dick-positive individuals given toxin for the purpose of
developing active immunity become Dick test-negative within 24 hours, days before
humoral antitoxin could be demonstrated? There is no answer available for this
phenomenon if, in fact, it is true. Little, if anything, has been said about it since that
time, and the observation may have been difficult to reproduce. Certainly, we have
plenty of examples of antigens, drugs, chemicals, etc., saturating receptor sites and
minimizing the effects of second encounters. With cells like mast cells and basophils
we can degranulate them slowly by binding an allergen to the IgE on their
membranes and prevent them from regranulating by continuing antigenic exposure,
thus desensitizing them. In all these examples, however, the initial encounter that
desensitizes produces an effect per se. This is not the case ifTrask's observations were
correct. We do have phenomena in immunology where very large doses of antigen
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can exceed the upper threshold for an immune response and cause a state of
nonresponsiveness (high zone tolerance) that is not associated with an initial effector
response.
4. Can the nasal diphtheria organism which produces only mild illness in young
children be the same as that which can be released from the pharynx in adults and
children with severe illness associated with toxin production? We can answer"Yes" to
this question but between the lines of Trask's queries obviously lies the question, "If
so, how come?" Here we can report the fascinating fact that diphtheria exotoxin is
well absorbed across the mucous membranes of the pharynx but is only poorly
absorbed across the nasal mucosa and by the tonsils. (Why?) Is this a matter of
appropriate transport systems, different concentrations of local humoral immunity
(secretory IgA) or what? The full explanation will require more work on the subject.
5. Why does immunization against diphtheria on the third, sixth, and ninth days
of life fail to produce adequate protection? This, at least is a question we can answer
well. The antigen in the infants will combine with maternal antibody and be
neutralized before it can be fully immunogenic. The baby, however, is not yet
equipped to make his best IgG response and doses so close together would fail even in
the absence of maternal antibody. It is interesting that Trask comments on the
practice of giving antisera with antigen, a procedure that is still used today; e.g., in
giving live measles virus vaccine to young children. Immunologists now have good
evidence that such combinations could in fact trigger suppressor T cells and block
any chance of making a good immune response.
6. Why are not diphtheria and tetanus toxin general protoplasmic poisons? A dose
of tetanus toxoid sufficient to kill 1,000 mice, he reported, won't kill a seven-gram
spider. Tetanus toxin, a least, will produce its characteristic effects on the nervous
system in most vertebrates, but birds are resistant and frogs only react if you heat
them. Here again, we can suggest specific receptor sites for the toxin. Most animals
with nervous systems similar to man will be susceptible. But wouldn't you have
guessed that birds would be susceptible?
7. Finally, Dr. Trask asked why adult patients at Yale-New Haven Hospital and
elsewhere with pneumococcal pneumonia frequently succumbed while children may
have a relatively easy time with the same organism? There is no shortage of
pneumococcal pneumonia today and in our society the observation is only true ifone
compares children with debilitated adults. There really is no difference in the
handling of the organism by children. We frequently see adults who have smoked,
aspirated, and generally abused the macrophages lining the alveoli into a noncomba-
tive state. These adults certainly may lose the battle with pneumococcal organisms.
That the above answers would stimulate the mind of a Dr. Trask to produce twice
the number of questions is certain. That's fine; after all, good questions are a
prerequisite to worthwhile studies that produce useful results. We can but hope that
when the editor of the Yale Journal in 2027 decides to get a 100-year perspective
applied to Trask's questions, the answers that will appear in the Journal will be
complete and reflect the perfected state of the medical arts we can all predict. In the
meantime, previously unanswered questions may provoke improved powers of
observation and, therefore, make many of us more thoughtful MDs and investiga-
tors.
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